DMPK hypermethylation in sperm cells of myotonic dystrophy type 1 patients

Eur J Hum Genet. 2022 Aug;30(8):980-983. doi: 10.1038/s41431-021-00999-3. Epub 2021 Nov 15.

Abstract

Myotonic dystrophy type 1 (DM1) is an autosomal dominant muscular dystrophy that results from a CTG expansion (50-4000 copies) in the 3' UTR of the DMPK gene. The disease is classified into four or five somewhat overlapping forms, which incompletely correlate with expansion size in somatic cells of patients. With rare exception, it is affected mothers who transmit the congenital (CDM1) and most severe form of the disease. Why CDM1 is hardly ever transmitted by fathers remains unknown. One model to explain the almost exclusive transmission of CDM1 by affected mothers suggests a selection against hypermethylated large expansions in the germline of male patients. By assessing DNA methylation upstream to the CTG expansion in motile sperm cells of four DM1 patients, together with availability of human embryonic stem cell (hESCs) lines with paternally inherited hypermethylated expansions, we exclude the possibility that DMPK hypermethylation leads to selection against viable sperm cells (as indicated by motility) in DM1 patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Methylation*
  • Humans
  • Male
  • Myotonic Dystrophy* / genetics
  • Myotonin-Protein Kinase* / genetics
  • Semen
  • Spermatozoa
  • Trinucleotide Repeat Expansion

Substances

  • DMPK protein, human
  • Myotonin-Protein Kinase